FDA Adverse Event Injury Summary report: N

VANGUARD COMPLETE KNEE SYSTEM, TIBIAL TRAY

MDR report key: 7292117 · Received February 23, 2018

Report

Report Number
0001825034-2018-01362
Event Type
Injury
Date Received
February 23, 2018
Date of Event
September 20, 2016
Report Date
February 23, 2018
Manufacturer
ZIMMER BIOMET, INC.
Product Code
JWH
PMA / PMN Number
PK132873
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(6). MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT. PLEASE SEE ASSOCIATED REPORTS: 0001825034 - 2018 - 01361, 0001825034 - 2018 - 01368, 0001825034 - 2018 - 01370. CONCOMITANT: 195919 VGXP INTLK FEMORAL LT 57.5 LOT 050320; 195809 VGXP XP E1 TIB BRG LL 11X63 LOT 811970; 195879 VGXP XP E1 TIB BRG LM 11X63 LOT 811110. (B)(6). REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM THE CUSTOMER. DHR WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. REVIEW OF THE COMPLAINT HISTORY DETERMINED THAT NO FURTHER ACTION IS REQUIRED AS NO WERE TRENDS IDENTIFIED. ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS. THIS REPORT IS BEING SUBMITTED LATE AS IT HAS BEEN IDENTIFIED IN REMEDIATION. DEVICE REMAINS IMPLANTED.

Description of Event or Problem · 1

IT WAS REPORTED IN THE STUDY THE PATIENT HAD MODERATE AND SEVERE PAIN, AMBULATION DIFFICULTIES, TROUBLE PERFORMING NORMAL ACTIVITIES, LOSS OF RANGE OF MOTION, LIMPING, FEELINGS OF KNEE INSTABILITY. NO FURTHER INFORMATION HAS BEEN MADE AVAILABLE AT THIS TIME.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
136417 VANGUARD COMPLETE KNEE SYSTEM, TIBIAL TRAY PROSTHESIS, KNEE JWH ZIMMER BIOMET, INC. N/A 639630

Patients

Seq Age Sex Outcome Treatment
1 80 YR Other